Klintmalm G - Search Results

1

Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.

Levy G, Villamil F, Samuel D, Sanjuan F, Grazi GL, Wu Y, Marotta P, Boillot O, Muehlbacher F, Klintmalm G; LIS2T Study Group. Levy G, et al. Among authors: klintmalm g. Transplantation. 2004 Jun 15;77(11):1632-8. doi: 10.1097/01.tp.0000129095.51031.42. Transplantation. 2004. PMID: 15201658 Clinical Trial.

2

Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome.

Mor E, Gonwa TA, Husberg BS, Goldstein RM, Klintmalm GB. Mor E, et al. Among authors: klintmalm gb. Transplantation. 1992 Nov;54(5):821-4. doi: 10.1097/00007890-199211000-00010. Transplantation. 1992. PMID: 1279849

3

Simultaneous liver and renal transplantation in man.

Gonwa TA, Nery JR, Husberg BS, Klintmalm GB. Gonwa TA, et al. Among authors: klintmalm gb. Transplantation. 1988 Nov;46(5):690-3. doi: 10.1097/00007890-198811000-00013. Transplantation. 1988. PMID: 3057691

4

Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.

Klintmalm G, Säwe J, Ringdén O, von Bahr C, Magnusson A. Klintmalm G, et al. Transplantation. 1985 Feb;39(2):132-7. doi: 10.1097/00007890-198502000-00005. Transplantation. 1985. PMID: 3881851

5

The impact of immunosuppressive regimens on the cost of liver transplantation--results from the U.S. FK506 multicenter trial.

Lake JR, Gorman KJ, Esquivel CO, Wiesner RH, Klintmalm GB, Miller CM, Shaw BW, Gordon JA. Lake JR, et al. Among authors: klintmalm gb. Transplantation. 1995 Nov 27;60(10):1089-95. doi: 10.1097/00007890-199511270-00005. Transplantation. 1995. PMID: 7482713 Clinical Trial.

6

FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects.

Bäckman L, Nicar M, Levy M, Distant D, Eisenstein C, Renard T, Goldstein R, Husberg B, Gonwa TA, Klintmalm G. Bäckman L, et al. Among authors: klintmalm g. Transplantation. 1994 Feb 27;57(4):519-25. Transplantation. 1994. PMID: 7509516

7

FK 506: an update.

Klintmalm GB. Klintmalm GB. Clin Transplant. 1994 Apr;8(2 Pt 2):207-10. Clin Transplant. 1994. PMID: 7517226 Review.

8

Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.

Abouljoud MS, Levy MF, Klintmalm GB. Abouljoud MS, et al. Among authors: klintmalm gb. Transplant Proc. 1995 Feb;27(1):1121-3. Transplant Proc. 1995. PMID: 7533360 Clinical Trial. No abstract available.

9

Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.

Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW Jr, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Klintmalm GB, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):641-3. Transplant Proc. 1993. PMID: 7679828 No abstract available.

10

Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.

Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW Jr, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Klintmalm GB, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):679-88. Transplant Proc. 1993. PMID: 7679840 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

501 results

Search Page